Stay updated with breaking news from Insulin Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cost is a huge barrier to insulin access in LMICs. Human insulins are still out of the reach of many people with diabetes. When available, analogues are very expensive and can cost two to six times more than human insulins. There are also wide variations in price across countries
If Democrats have their way, new regulations will make it harder for Americans to access life-saving pharmaceuticals such as insulin.
A bipartisan bill was introduced to the Senate to reduce the soaring price of insulin for patients on both Medicare and private insurance plans.
Kaitlyn Wright and her mother, of Marks, Mississippi, had to look outside the Delta for help in treating Kaitlyn's diabetes. Here's why.
Accessing Insulin in Developing Countries NEW YORK, New York — The World Health Organization reports that, in 2014, diabetes affected an estimated 422 million people worldwide. In 2016, diabetes accounted for around 1.6 million annual global deaths. When left untreated, diabetes can lead to long-term health problems. Additionally, the chances of premature death are higher without treatment. Developing countries often face these outcomes as they often experience struggles accessing insulin. Diabetes in Developing Countries Reports indicate that the majority of diabetic people live in develo...